Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal Bleed.
Conclusion and Relevance: Resuming anticoagulation within 7 days of admission for an index GIB was not associated with a recurrent GIB within 90 days of discharge.
PMID: 32141301 [PubMed - as supplied by publisher]
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Valanejad SM, Davis KA, Nisly SA Tags: Ann Pharmacother Source Type: research
More News: Atrial Fibrillation | Bleeding | Blood Transusion | Coumadin | Drugs & Pharmacology | Gastroenterology | Inflammatory Bowel Disease | Study | Thrombocytopenia | Warfarin